Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Ginkgo Bioworks

Explore full profile

Automated cell programming and biological engineering platform.

Boston, United StatesFounded 2008Biotech & Life Sciences
Valuation $566M Market cap · Aug/2026
Revenue $106M Latest reported FY

At a glance

Founded
2008
Headquarters
Boston, United States
Listing
Public via SPAC 2021
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Investors

25 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed4 investors entered at this stage

Series A7 investors entered at this stage

Series B and later14 investors entered at this stage

Employees mapped 520 incl. 22 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 13 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 5 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Boston HQ
Book a demo for the full country breakdown
Web traffic by country
5.7K monthly visits
across markets
🇺🇸 United States80.7%
🇯🇵 Japan10.5%
🇮🇳 India5.3%
🇩🇪 Germany3.5%
🇮🇹 Italy1.8%
Top 5 markets shown

Patents

Estimated portfolio value
$349M

252 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Ginkgo Bioworks was the backer or acquirer, 2017–2024. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

19 deals across Ginkgo Bioworks's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Where Ginkgo Bioworks deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        Ginkgo Bioworks's portfolio, mapped.

        Stage
        Period
        19 of 19 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about Ginkgo Bioworks on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Ginkgo Bioworks on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.